Showing results (2381-2390 of 9,924) with videos related to
Sort By:
Pageof 993
Bone Marrow Transplantation|May 20, 2024
Allogeneic haematopoietic stem cell transplantation might overcome the poor prognosis of adolescents and adult patients with T-lineage acute lymphoblastic leukaemia and CDKN2 deletionXiaoshan Hu, Zhixiang Wang, Yuting Qin, et al.Bone Marrow Transplantation|April 16, 2024
Outcomes of allogeneic haematopoietic cell transplantation for myelofibrosis in children and adolescents: the retrospective study of the EBMT Paediatric Diseases WPJacek Wachowiak, Jacques-Emmanuel Galimard, Arnaud Dalissier, et al.Bone Marrow Transplantation|January 9, 2026
Validation of risk stratification and novel prognostic biomarkers in asian adult HSCT recipients with TA-TMA: A multicenter real-world studyYibo Wu, Xiaolin Yuan, Lieguang Chen, et al.Bone Marrow Transplantation|November 18, 2025
Long-term survival outcomes of allo-HCT in AML with fludarabine/melphalan conditioning and tacrolimus/sirolimus GVHD prophylaxisAmandeep Salhotra, Dongyun Yang, Monzr M Al Malki, et al.Bone Marrow Transplantation|November 27, 2025
Comparison of anti-human T cell globulins on immune reconstitution and early infections after autologous transplant in patients with multiple sclerosisJohanna Richter, Nico Gagelmann, Felix Fischbach, et al.Bone Marrow Transplantation|December 3, 2025
Posttransplant cyclophosphamide versus antithymocyte globulin in patients with cardiovascular comorbidity undergoing allogeneic hematopoietic cell transplantation for acute myeloid leukaemia in first complete remission from unrelated donors: a retrospective matched-pair analysis from the ALWP of the EBMTJan Vydra, Allain-Thibeault Ferhat, Nicolaus Kröger, et al.Bone Marrow Transplantation|December 18, 2024
Fludarabine melphalan reduced intensity conditioning vs radiation-based myeloablative conditioning in patients undergoing allogeneic transplantation for acute myeloid leukemia with measurable residual diseaseAmanda Blackmon, Michelle Afkhami, Dongyun Yang, et al.Bone Marrow Transplantation|December 20, 2024
Optimal timing and impact of allogeneic peripheral blood stem cell transplantation in adult T-cell lymphoblastic lymphoma: insights from a large cohort multi-center real-world study in ShanghaiFangfang Yu, Jiahua Niu, Jianmin Yang, et al.Bone Marrow Transplantation|January 9, 2025
aGvHDtrackR and cGvHDtrackR: shiny applications for graft versus host disease management and clinical data collectionMarco Maria Sindoni, Francesca Limido, Anita Toso, et al.Bone Marrow Transplantation|February 13, 2025
The haematopoietic cell transplantation comorbidity index predicts clinical outcomes for severe aplastic anaemia patients after haploidentical haematopoietic stem cell transplantationMing-Hao Lin, Xiao-Jun Huang, Lan-Ping Xu, et al.Pageof 993